Form 8-K - Current report:
SEC Accession No. 0001437749-26-025074
Filing Date
2026-07-30
Accepted
2026-07-30 16:31:02
Documents
12
Period of Report
2026-07-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20260730_8k.htm   iXBRL 8-K 43721
  Complete submission text file 0001437749-26-025074.txt   181641

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20260729.xsd EX-101.SCH 3579
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20260729_def.xml EX-101.DEF 11807
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20260729_lab.xml EX-101.LAB 15858
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20260729_pre.xml EX-101.PRE 12022
15 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20260730_8k_htm.xml XML 2933
Mailing Address 3300 BEE CAVE ROAD SUITE 650-227 AUSTIN TX 78746
Business Address 3300 BEE CAVE ROAD SUITE 650-227 AUSTIN TX 78746 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 261223840
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)